Tenax Therapeutics Inc (TENX NASDAQ) stock market data APIs
$1.9839
-0.01(-0.5%)
as of October 2, 2026
Try our APIs with
free plan!
Tenax Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Prev. Close
1.9839
Open
1.9783
High
1.9984
Low
1.9244
52 wk Range
1.31-19.4
Market Cap
74 099 K
Shares Outstanding
37 424 K
EPS
-0.35
Beta
0.823
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tenax Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tenax Therapeutics Inc data using free add-ons & libraries
Get Tenax Therapeutics Inc Fundamental Data
Tenax Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 486 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-31
- EPS/Forecast: -0.38
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tenax Therapeutics Inc News
New
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls tha...
Tenax finds benefit in sicker patient subgroup after Phase 3 trial miss
[Human heart, 3d rendering, medically accurate illustration of the human heart anatomy with venous system] Design Cells/iStock via Getty Images Tenax Therapeutics (TENX [https://seekingalpha.com/symb...
Tenax rises on over $1.8M insider buying
[Green arrow pointing up and a dollar sign] * Cardiopulmonary drug developer Tenax Therapeutics (TENX [https://seekingalpha.com/symbol/TENX]) added nearly 13% in the premarket trading on Tuesday af...
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inf...
Get Tenax Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.